Clinical Trial Update: Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing rivaroxaban versus apixaban for cerebral venous thrombosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Venous Thrombosis

Drugs mentioned

• Apixaban (apixaban)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Cerebral Venous Thrombosis | Phase 3 | Status: RECRUITING